Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00717158 · ClinicalTrials.gov registry record · NA

Lifestyle Intervention's Impact on Health Care Costs

A NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
147
Enrollment target
1
Study location

NCT00717158: Completed NA study of Obesity and Diabetes Mellitus, Type 2, sponsored by University of Virginia.

NCT00717158 is a NA study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by University of Virginia. The registered enrollment target is 147 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00717158, a NA study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
147 participants
Enrollment target
1
Study location

Study Summary

The ICAN Pilot project aims to evaluate the differences in economic, clinical and quality of life outcomes of a nutrition intervention involving lifestyle case management and medical nutrition therapy by a registered dietitian compared to usual medical care in obese persons with type 2 diabetes. The intervention is aimed at moderate weight loss (\> 5-10%), improvement in diet quality and an increase in physical activity.

Interventions

  • BEHAVIORAL Usual medical care
  • BEHAVIORAL Lifestyle Case management

Study Locations (1)

Virginia

  • University of Virginia School of Medicine - Charlottesville

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2001-05
Est. Completion 2003-02
Phase NA
University of Virginia

449 total trials

What the finished NCT00717158 record still lists

NCT00717158 is an interventional study that assigns participants to a tested intervention. The registered 147 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Usual medical care is the first listed.

NCT00717158 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT00717158 about?

NCT00717158 is a clinical study titled "Lifestyle Intervention's Impact on Health Care Costs". The ICAN Pilot project aims to evaluate the differences in economic, clinical and quality of life outcomes of a nutrition intervention involving lifestyle case management and medical nutrition therapy by a registered dietitian compared to usual medical care in obese persons with type 2 diabetes. The...

What is the current status of trial NCT00717158?

This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2001-05. Estimated completion is 2003-02.

What conditions does trial NCT00717158 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00717158?

The interventions under investigation include: Usual medical care (BEHAVIORAL), Lifestyle Case management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00717158?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00717158 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00717158's enrollment target sits among peer trials

147 391st of 1053 higher than 663 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04396613 · 147 participants · NA

    Wound Closure Techniques in Primary Spine Surgery

  • NCT04851119 · 147 participants · Phase 1

    Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NCT05523947 · 147 participants · Phase 1

    Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

  • NCT06121843 · 147 participants · Phase 1

    A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00717158, the US trial registry maintained by the National Library of Medicine. NCT00717158 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.